Annual Short Term Debt
$12.78 M
+$2.40 M+23.10%
31 December 2023
Summary:
Beam Therapeutics annual short term debt is currently $12.78 million, with the most recent change of +$2.40 million (+23.10%) on 31 December 2023. During the last 3 years, it has risen by +$8.56 million (+202.94%). BEAM annual short term debt is now at all-time high.BEAM Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$12.94 M
+$295.00 K+2.33%
30 September 2024
Summary:
Beam Therapeutics quarterly short term debt is currently $12.94 million, with the most recent change of +$295.00 thousand (+2.33%) on 30 September 2024. Over the past year, it has increased by +$985.00 thousand (+8.24%). BEAM quarterly short term debt is now at all-time high.BEAM Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BEAM Short Term Debt Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +23.1% | +8.2% |
3 y3 years | +202.9% | +99.5% |
5 y5 years | +100.0% | +370.1% |
BEAM Short Term Debt High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | at high | +202.9% | at high | +99.5% |
5 y | 5 years | at high | at high | +370.1% | |
alltime | all time | at high | at high |
Beam Therapeutics Short Term Debt History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $12.94 M(+2.3%) |
June 2024 | - | $12.64 M(+3.8%) |
Mar 2024 | - | $12.18 M(-4.7%) |
Dec 2023 | $12.78 M(+23.1%) | $12.78 M(+6.9%) |
Sept 2023 | - | $11.95 M(+4.0%) |
June 2023 | - | $11.49 M(+3.0%) |
Mar 2023 | - | $11.16 M(+7.5%) |
Dec 2022 | $10.38 M(+37.7%) | $10.38 M(+5.7%) |
Sept 2022 | - | $9.82 M(+3.3%) |
June 2022 | - | $9.51 M(+1.6%) |
Mar 2022 | - | $9.36 M(+24.1%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2021 | $7.54 M(+78.8%) | $7.54 M(+16.3%) |
Sept 2021 | - | $6.48 M(+85.7%) |
June 2021 | - | $3.49 M(-10.1%) |
Mar 2021 | - | $3.88 M(-7.9%) |
Dec 2020 | $4.22 M(-2.7%) | $4.22 M(-2.8%) |
Sept 2020 | - | $4.34 M(-7.6%) |
June 2020 | - | $4.70 M(-0.0%) |
Mar 2020 | - | $4.70 M(+8.3%) |
Dec 2019 | $4.34 M(>+9900.0%) | $4.34 M(+57.6%) |
Sept 2019 | - | $2.75 M(+40.3%) |
June 2019 | - | $1.96 M(>+9900.0%) |
Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Beam Therapeutics annual short term debt?
- What is the all time high annual short term debt for Beam Therapeutics?
- What is Beam Therapeutics annual short term debt year-on-year change?
- What is Beam Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Beam Therapeutics?
- What is Beam Therapeutics quarterly short term debt year-on-year change?
What is Beam Therapeutics annual short term debt?
The current annual short term debt of BEAM is $12.78 M
What is the all time high annual short term debt for Beam Therapeutics?
Beam Therapeutics all-time high annual short term debt is $12.78 M
What is Beam Therapeutics annual short term debt year-on-year change?
Over the past year, BEAM annual short term debt has changed by +$2.40 M (+23.10%)
What is Beam Therapeutics quarterly short term debt?
The current quarterly short term debt of BEAM is $12.94 M
What is the all time high quarterly short term debt for Beam Therapeutics?
Beam Therapeutics all-time high quarterly short term debt is $12.94 M
What is Beam Therapeutics quarterly short term debt year-on-year change?
Over the past year, BEAM quarterly short term debt has changed by +$985.00 K (+8.24%)